Sachs Associates would like to say we enjoyed hosting you at our 7th Annual Neuroscience Innovation Forum (Sachs_NIF). We would like to thank those who joined us in-person in San Francisco and those who participated virtually last week. A special thank you goes to the excellent lineup of sponsors, chairs, panelists and presenters who made such a broad and interesting programme possible and to those who participated in-person and during the virtual week.
In line with the positive sentiment around the sector, the past conference has proven to be successful in supporting our community, with 367 people from 24 countries registered and a 25% increase in meetings.
To view photos form the event, please navigate to the 'PHOTOS’ tab. To watch a session on-demand, please navigate to the 'RECORDINGS' tab and select the panel or a session that you want to view. To view showcases, please click on the 'PRESENTERS' tab. Each company will have a showcase button, which will allow you to view their presentation. The Online Meeting System and event portal will be available for review, messaging people and exchanging contacts with people you did not have a chance to meet until the 7th of February 2024, 00:00 PST.
We look forward to welcoming you again to our future events!
SILVER SPONSOR:

CONTRIBUTING SPONSOR:

Presenting Companies Included:
Acasti Pharma Inc.
Actinogen Medical Ltd.
AgenT S.A.S.
AlgoTx



GeNeuro SA

HanAll Biopharma

Lys Therapeutics



Parow Entheobiosciences LLC


Quince Therapeutics

Theranexus SA


Confirmed Keynote Speakers Included:
HT
Harry Tracy
President, NI Research Inc.
JJ
Jonathan Javitt
CEO, NRx Pharmaceuticals, Inc.
MP
Marc Penn
Chief Medical Officer, Keystone Bio, Inc.
Speakers and Chairs Included:
BL
Bruce Leuchter
President & CEO, Neurvati Neurosciences, Inc.
DL
Daniel Lee
Partner, PJT Partners
GM
Gregor Macdonald
VP, Head of BD & Licensing, Search & Assessment, H. Lundbeck A/S
Jay Olson
Managing Director & Senior Analyst, Oppenheimer & Co. Inc.
JC
Jeffrey Cohen
Director of Research, Ladenburg Thalmann & Co. Inc.
Joel Sandler
Associate Partner, Ipsos Healthcare Advisory Service
MG
Murali Gopalakrishnan
Global Head, Neuroscience Search & Evaluation, Corporate Strategy Office, AbbVie, Inc.
SK
Sumant Kulkarni
Managing Director, Biotechnology Equity Research, Canaccord Genuity LLC
TS
Thomas Shrader
Managing Director & Healthcare Analyst, BTIG, LLC
AG
Alexander Gebauer
Co-Founder & Executive Chairman, Galimedix Therapeutics, Inc.
AC
Almira Chabi
Chief Medical Officer & Chief Development Officer, HanAll Biopharma
AM
Andrea Malizia
CEO, IAMA Therapeutics S.r.l.
AM
Arun Mistry
CMO, Minoryx Therapeutics S.L.
CA
Carolina Aguilar
Co-Founder & CEO, INBRAIN Neuroelectronics
CW
Chris Witowski
Co-Founder & CEO, Psilera Inc.
CT
Christian Thomsen
Global Head, CNS BD&L, Boehringer Ingelheim International GmbH
CT
Christina Trojel-Hansen
Entrepreneur in Residence, ARCH Venture Partners
DT
Dirk Thye
CEO & CMO, Quince Therapeutics
DD
Doug Drysdale
CEO, Cybin Inc.
DC
Douglas Crawford
Managing General Partner, Mission BioCapital
GS
Gaia Skibinski
Director of Discovery & Translational Research, The Michael J. Fox Foundation for Parkinson's Research
IL
Ilise Lombardo
CEO, Noema Pharma AG
IS
Ivo Staijen
Head, Public Equity, HBM Partners AG
JB
Jeff Berkowitz
CEO, Real Endpoints
JM
Jesús Martin-Garcia
CEO, GeNeuro SA
JA
John Alam
Founder & CEO, CervoMed Inc.
KN
Kabir Nath
CEO, Compass Pathways
KB
Kees Been
CEO, KyNexis Therapeutics
KM
Ken Mariash
CEO, Sinaptica Therapeutics, Inc.
LR
Lisa Ricciardi
President & CEO, Cognition Therapeutics, Inc.
LK
Lothar Krinke
CEO, Newronika S.p.A.
Lynn Durham
Founder & CEO, STALICLA SA
MB
Marine Beurdeley
Senior Director, Global Business Development, Ipsen
PD
Paolo Di Giorgio
Managing Director & CEO, Angelini Ventures S.p.A.
SK
Sahil Kirpekar
Managing Partner, Lumina Life Sciences
SL
Seth Lederman
Chairman & CEO, Tonix Pharmaceuticals Holding Corp.
TL
Tim Luker
VP, Lilly Ventures, Eli Lilly and Company
TH
Todd Haim
Director, Office of Strategic Extramural Programs, National Institute on Aging